| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.
|
Hepatology
|
2003
|
16.40
|
|
2
|
Statins and the risk of colorectal cancer.
|
N Engl J Med
|
2005
|
6.86
|
|
3
|
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma.
|
Nat Med
|
2010
|
4.81
|
|
4
|
Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer.
|
Cancer Res
|
2003
|
4.30
|
|
5
|
Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation.
|
Cancer Res
|
2007
|
2.97
|
|
6
|
The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism.
|
Cell
|
2012
|
2.78
|
|
7
|
Hepatic fat fraction: MR imaging for quantitative measurement and display--early experience.
|
Radiology
|
2005
|
2.69
|
|
8
|
Genetic variation in 8q24 associated with risk of colorectal cancer.
|
Cancer Biol Ther
|
2007
|
2.32
|
|
9
|
The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial.
|
Am J Gastroenterol
|
2010
|
2.30
|
|
10
|
Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease.
|
Blood
|
2011
|
2.24
|
|
11
|
One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study.
|
Am J Gastroenterol
|
2005
|
2.04
|
|
12
|
BLM heterozygosity and the risk of colorectal cancer.
|
Science
|
2002
|
2.03
|
|
13
|
Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD.
|
Am J Gastroenterol
|
2006
|
1.91
|
|
14
|
Low Paneth cell numbers at onset of gastrointestinal graft-versus-host disease identify patients at high risk for nonrelapse mortality.
|
Blood
|
2013
|
1.82
|
|
15
|
Jumbo forceps are superior to standard large-capacity forceps in obtaining diagnostically adequate inflammatory bowel disease surveillance biopsy specimens.
|
Gastrointest Endosc
|
2007
|
1.72
|
|
16
|
Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial.
|
Clin Gastroenterol Hepatol
|
2007
|
1.71
|
|
17
|
Oncogenic KRAS is not necessary for Wnt signalling activation in APC-associated FAP adenomas.
|
J Pathol
|
2010
|
1.68
|
|
18
|
Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence.
|
Liver Transpl
|
2007
|
1.61
|
|
19
|
A histologically defined subset of high-grade dysplasia in Barrett mucosa is predictive of associated carcinoma.
|
Am J Clin Pathol
|
2009
|
1.59
|
|
20
|
Histopathology of interval (delayed) appendectomy specimens: strong association with granulomatous and xanthogranulomatous appendicitis.
|
Am J Surg Pathol
|
2003
|
1.41
|
|
21
|
Hepatocyte-derived Snail1 propagates liver fibrosis progression.
|
Mol Cell Biol
|
2011
|
1.32
|
|
22
|
Smoking, gender, and ethnicity predict somatic BRAF mutations in colorectal cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
1.31
|
|
23
|
The molecular basis of pancreatic fibrosis: common stromal gene expression in chronic pancreatitis and pancreatic adenocarcinoma.
|
Pancreas
|
2004
|
1.31
|
|
24
|
Endothelial PAS domain protein 1 activates the inflammatory response in the intestinal epithelium to promote colitis in mice.
|
Gastroenterology
|
2013
|
1.30
|
|
25
|
Expression and effect of inhibition of the ubiquitin-conjugating enzyme E2C on esophageal adenocarcinoma.
|
Neoplasia
|
2006
|
1.28
|
|
26
|
The MLH1 D132H variant is associated with susceptibility to sporadic colorectal cancer.
|
Nat Genet
|
2004
|
1.25
|
|
27
|
Expression of hexokinase II and Glut-1 in untreated human breast cancer.
|
Nucl Med Biol
|
2002
|
1.23
|
|
28
|
Lifestyle, occupational, and reproductive factors in relation to pancreatic cancer risk.
|
Pancreas
|
2007
|
1.21
|
|
29
|
Accurate molecular classification of human cancers based on gene expression using a simple classifier with a pathological tree-based framework.
|
Am J Pathol
|
2003
|
1.20
|
|
30
|
Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.
|
Hepatology
|
2009
|
1.18
|
|
31
|
Hypoxia-inducible factor-2α activation promotes colorectal cancer progression by dysregulating iron homeostasis.
|
Cancer Res
|
2012
|
1.17
|
|
32
|
Adrenomedullin is expressed in pancreatic cancer and stimulates cell proliferation and invasion in an autocrine manner via the adrenomedullin receptor, ADMR.
|
Cancer Res
|
2007
|
1.17
|
|
33
|
A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer.
|
Cancer
|
2013
|
1.16
|
|
34
|
Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreas.
|
J Gastrointest Surg
|
2003
|
1.16
|
|
35
|
Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation.
|
Liver Transpl
|
2002
|
1.14
|
|
36
|
Collagenous sprue: a clinicopathologic study of 12 cases.
|
Am J Surg Pathol
|
2009
|
1.13
|
|
37
|
Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial.
|
Hepatology
|
2010
|
1.12
|
|
38
|
Acute liver failure due to amoxicillin and amoxicillin/clavulanate.
|
Dig Dis Sci
|
2005
|
1.12
|
|
39
|
An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer.
|
Cancer Res
|
2004
|
1.12
|
|
40
|
Pathogenic Yersinia DNA is detected in bowel and mesenteric lymph nodes from patients with Crohn's disease.
|
Am J Surg Pathol
|
2003
|
1.09
|
|
41
|
Phase I study of oxaliplatin, full-dose gemcitabine, and concurrent radiation therapy in pancreatic cancer.
|
J Clin Oncol
|
2007
|
1.08
|
|
42
|
Reduced severity of a mouse colitis model with angiotensin converting enzyme inhibition.
|
Dig Dis Sci
|
2007
|
1.08
|
|
43
|
Curcumin promotes apoptosis, increases chemosensitivity, and inhibits nuclear factor kappaB in esophageal adenocarcinoma.
|
Transl Oncol
|
2010
|
1.06
|
|
44
|
The association of body mass index and pancreatic cancer in residents of southeastern Michigan, 1996-1999.
|
Am J Epidemiol
|
2005
|
1.06
|
|
45
|
Primary pulmonary adenocarcinoma with intestinal differentiation mimicking metastatic colorectal carcinoma: case report and review of literature.
|
Am J Clin Pathol
|
2009
|
1.05
|
|
46
|
Lynch syndrome-associated neoplasms: a discussion on histopathology and immunohistochemistry.
|
Fam Cancer
|
2013
|
1.03
|
|
47
|
Adrenocortical carcinoma is a lynch syndrome-associated cancer.
|
J Clin Oncol
|
2013
|
1.02
|
|
48
|
IgG4-related sclerosing cholangitis in the absence of autoimmune pancreatitis mimicking extrahepatic cholangiocarcinoma.
|
Scand J Gastroenterol
|
2015
|
1.01
|
|
49
|
Human papillomavirus is not associated with colorectal cancer in a large international study.
|
Cancer Causes Control
|
2010
|
0.98
|
|
50
|
L-type amino acid transporter-1 overexpression and melphalan sensitivity in Barrett's adenocarcinoma.
|
Neoplasia
|
2004
|
0.97
|
|
51
|
Lifestyle, occupational, and reproductive factors and risk of colorectal cancer.
|
Dis Colon Rectum
|
2010
|
0.97
|
|
52
|
A phase II study of preoperative capecitabine and radiation therapy in patients with rectal cancer.
|
Am J Clin Oncol
|
2007
|
0.96
|
|
53
|
Sensitization of pancreatic cancer to chemoradiation by the Chk1 inhibitor MK8776.
|
Clin Cancer Res
|
2013
|
0.95
|
|
54
|
Are ulcers a marker for invasive carcinoma in Barrett's esophagus? Data from a diagnostic variability study with clinical follow-up.
|
Am J Gastroenterol
|
2002
|
0.94
|
|
55
|
The differential diagnosis of colitis in endoscopic biopsy specimens: a review article.
|
Arch Pathol Lab Med
|
2012
|
0.94
|
|
56
|
Debating deposits: an interobserver variability study of lymph nodes and pericolonic tumor deposits in colonic adenocarcinoma.
|
Arch Pathol Lab Med
|
2013
|
0.92
|
|
57
|
Immunohistochemical staining for p63 is useful in the diagnosis of anal squamous cell carcinomas.
|
Am J Surg Pathol
|
2007
|
0.92
|
|
58
|
CDX2 polymorphisms, RNA expression, and risk of colorectal cancer.
|
Cancer Res
|
2005
|
0.91
|
|
59
|
Life-long learning and self-assessment.
|
Arch Pathol Lab Med
|
2012
|
0.90
|
|
60
|
Adenoma-infiltrating lymphocytes (AILs) are a potential marker of hereditary nonpolyposis colorectal cancer.
|
Am J Surg Pathol
|
2008
|
0.89
|
|
61
|
Identification of a Specific Vimentin Isoform That Induces an Antibody Response in Pancreatic Cancer.
|
Biomark Insights
|
2006
|
0.89
|
|
62
|
Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours.
|
J Pathol
|
2002
|
0.89
|
|
63
|
Histopathology of ulcerative colitis in initial rectal biopsy in children.
|
Am J Surg Pathol
|
2002
|
0.89
|
|
64
|
Melanoma-associated antigens in esophageal adenocarcinoma: identification of novel MAGE-A10 splice variants.
|
Clin Cancer Res
|
2004
|
0.88
|
|
65
|
Gemcitabine-based combination chemotherapy followed by radiation with capecitabine as adjuvant therapy for resected pancreas cancer.
|
Int J Radiat Oncol Biol Phys
|
2009
|
0.87
|
|
66
|
The clinical significance of focally enhanced gastritis.
|
Am J Surg Pathol
|
2004
|
0.86
|
|
67
|
Risk of colorectal cancer in self-reported inflammatory bowel disease and modification of risk by statin and NSAID use.
|
Cancer
|
2010
|
0.85
|
|
68
|
The association between selected risk factors for pancreatic cancer and the expression of p53 and K-ras codon 12 mutations.
|
Int J Gastrointest Cancer
|
2006
|
0.85
|
|
69
|
Colorectal polyps in carriers of the APC I1307K polymorphism.
|
Dis Colon Rectum
|
2005
|
0.84
|
|
70
|
Differing molecular pathology of pancreatic adenocarcinoma in Egyptian and United States patients.
|
Int J Cancer
|
2006
|
0.84
|
|
71
|
Analysis of protein expression and gene mutation of c-kit in colorectal neuroendocrine carcinomas.
|
Am J Surg Pathol
|
2003
|
0.84
|
|
72
|
The clinical significance of focal active colitis in pediatric patients.
|
Am J Surg Pathol
|
2003
|
0.83
|
|
73
|
Effect of lifetime alcohol consumption on the histological severity of non-alcoholic fatty liver disease.
|
Liver Int
|
2013
|
0.81
|
|
74
|
Differences in K-ras and p53 gene mutations among pancreatic adenocarcinomas associated with regional environmental pollution.
|
Carcinogenesis
|
2007
|
0.81
|
|
75
|
The clinical significance of duodenal lymphocytosis with normal villus architecture.
|
Arch Pathol Lab Med
|
2013
|
0.79
|
|
76
|
Inflammatory bowel disease and familial adenomatous polyposis.
|
J Crohns Colitis
|
2012
|
0.79
|
|
77
|
The clinical significance of focally enhanced gastritis in children.
|
Am J Surg Pathol
|
2013
|
0.77
|
|
78
|
MLH1 promotor hypermethylation does not rule out a diagnosis of Lynch syndrome: a case report.
|
Fam Cancer
|
2015
|
0.77
|
|
79
|
Risk of other cancers in individuals with a family history of pancreas cancer.
|
J Gastrointest Cancer
|
2007
|
0.77
|
|
80
|
Distinct molecular features of colorectal cancer in Ghana.
|
Cancer Epidemiol
|
2013
|
0.76
|
|
81
|
A pathologist's survey on the reporting of sessile serrated adenomas/polyps.
|
J Clin Pathol
|
2014
|
0.76
|
|
82
|
Rab11a immunohistochemical analysis does not distinguish indefinite, low-, and high-grade dysplasia in Barrett esophagus.
|
Am J Clin Pathol
|
2005
|
0.75
|
|
83
|
Molecular diagnosis of Campylobacter jejuni infection in cases of focal active colitis.
|
Am J Surg Pathol
|
2006
|
0.75
|